Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine

Archives of Gynecology and Obstetrics

Volumn 279, Issue 6, 2009, Pages 803-807

  Barthell, Elisabeth ^a   Woelber, Linn ^b   Hellner, Karin ^c,d   Camerer, Birka ^a   Gieseking, Friederike ^b   Hauschild, Maik ^e   Mylonas, Ioannis ^a,g   Friese, Klaus ^a   Sings, Heather L ^f   Railkar, Radha ^f   Gause, Christine ^f   Barr, Eliav ^f  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e Frauenklinik und Brustzentrum   (Germany)

^f MERCK RESEARCH LABORATORIES   (United States)

^g NONE   (Germany)

Author keywords

Cervical cytology; Chlamydia trachomatis; Female; HPV prevalence; Neisseria gonorrhoeae; Prophylactic quadrivalent HPV vaccine

Indexed keywords

VIRUS ANTIBODY; VIRUS DNA; WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHLAMYDIA TRACHOMATIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; GENITAL TRACT INFECTION; GERMANY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PHASE 3 CLINICAL TRIAL; PREVALENCE; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CYTOLOGY; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ALPHAPAPILLOMAVIRUS; CHLAMYDIA INFECTIONS; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; GERMANY; GONORRHEA; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PREVALENCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; YOUNG ADULT;

EID: 67349099733     PISSN: 09320067     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00404-008-0806-1     Document Type: Article

References (23)

1. FX Bosch MM Manos N Muñoz 1995 Prevalence of human papillomavirus in cervical cancer: a worldwide perspective J Natl Cancer Inst 87 796 802 10.1093/jnci/87.11.796
2. L Gissmann H zur Hausen 1980 Partial characterization of viral DNA from human genital warts (condylomata acuminata) Int J Cancer 25 605 609 10.1002/ijc.2910250509 (Pubitemid 10156845)
3. CS Derkay DH Darrow 2000 Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment Otolaryngol Clin North Am 33 1127 1142 10.1016/S0030-6665(05)70270-X
4. A Hildesheim R Herrero S Wacholder 2007 Effect of human papillomavirus 16/18 L1 virus like particle vaccine among young women with preexisting infection: a randomized trial JAMA 298 743 753 10.1001/jama.298.7.743 (Pubitemid 47263157)
5. SM Garland M Hernandez-Avila CM Wheeler 2007 Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases N Engl J Med 356 1928 1943 10.1056/NEJMoa061760 (Pubitemid 46740303)
6. FUTURE II Study Group 2007 Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions N Engl J Med 356 1915 1927 10.1056/NEJMoa061741 (Pubitemid 46740302)
7. Delere Y, Meyer C, Reiter S (2007) Universal immunisation with human papillomavirus (HPV) vaccine among females aged 12-17 recommended in Germany. Euro Surveill 12:E0704052
8. Committee on Adolescent Health Care, ACOG Working Group on Immunization 2006 ACOG Committee Opinion No. 344: Human papillomavirus vaccination Obstet Gynecol 108 699 705
9. SM Garland M Steben M Hernandez-Avila 2007 Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines Clin Vaccine Immunol 14 792 795 10.1128/CVI.00478-06
10. SL Block T Nolan C Sattler 2006 Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women Pediatrics 118 2135 2145 10.1542/peds.2006-0461 (Pubitemid 46393698)
11. J Bryan F Taddeo D Skulsky 2006 Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas J Med Virol 78 117 124 10.1002/jmv.20512 (Pubitemid 41783851)
12. D Solomon D Davey R Kurman 2002 The 2001 Bethesda system: terminology for reporting results of cervical cytology JAMA 287 2114 2119 10.1001/jama.287.16. 2114 (Pubitemid 34437346)
13. D Dias J Van Doren S Schlottmann 2005 Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18 Clin Diag Lab Immunol 12 959 969 10.1128/CDLI.12.8.959-969.2005
14. J Paavonen 2008 Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6/11/16/18) vaccine clinical trials Curr Med Res Opin 24 1623 1634 10.1185/03007990802068151
15. EM de Villiers D Wagner A Schnieder 1992 Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study Gynecol Oncol 44 33 39 10.1016/0090-8258(92)90008-7
16. A Schneider H Hoyer B Lotz 2000 Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy Int J Cancer 89 529 534 10.1002/1097-0215(20001120)89: 6<529::AID-IJC11>3.0.CO;2-G
17. J Paavonen D Jenkins FX Bosch 2007 Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial Lancet 369 2161 2170 10.1016/S0140-6736(07)60946-5 (Pubitemid 46977438)
18. A Clad J Prillwitz KC Hintz 2001 Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction Eur J Clin Microbiol Infect Dis 20 324 328 (Pubitemid 33022728)
19. J Koch W Kirschner A Schaefer 1997 Bestimmung der Praevalenz genitaler HPV- und Chlamydia trachomatis-Infektionen in einem repraesentativen Querschnitt der weiblichen Normalbevoelkerung in Berlin Infektionsepidemiol Forsch 2 1 7
20. G Griesinger G Gille C Klapp 2007 Sexual behaviour and Chlamydia trachomatis infections in German female urban adolescents, 2004 Clin Microbiol Infect 13 436 439 10.1111/j.1469-0691.2006.01680.x (Pubitemid 46390233)
21. Robert-Koch-Institut EU bordernet surveillance on HIV/STD. http://www.rki de/cln-049/nn-196664/DE/Content/InfAZ/S/STD/Studien/Bordernet/Bordernet-inhalt html#doc207858bodyText3 , 2007
22. MM Madeleine T Anttila SM Schwartz 2007 Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors Int J Cancer 120 650 655 10.1002/ijc.22325
23. S Franceschi JS Smith BA van den 2007 Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study Sex Transm Dis 34 563 569 (Pubitemid 47207145)